ECP
LH icon

Empyrean Capital Partners’s Labcorp LH Stock Holding History

Empyrean Capital Partners’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-698,400
Closed -$95.7M – 68
2017
Q4 		$95.7M Hold
698,400
– – 4.33% 8
2017
Q3 		$90.6M Hold
698,400
– – 3.48% 7
2017
Q2 		$92.5M Buy
+698,400
New +$85.5M 3.94% 7

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Empyrean Capital Partners's LH Position: Q1 2018 in Review

Empyrean Capital Partners sold out of Labcorp (LH) in Q1 2018, closing a stake of 698,400 shares — an estimated $95.7M sold.

Empyrean Capital Partners first reported a position in LH in Q2 2017 and held it in 3 quarters. The position peaked at $95.7M in Q4 2017. 792 funds tracked by Wall St. Rank hold LH as of Q1 2018.

  • Empyrean Capital Partners reported no remaining Labcorp position as of Q1 2018 after selling out during the quarter.
  • Empyrean Capital Partners sold 698,400 Labcorp shares in Q1 2018, an estimated $95.7M.
  • Empyrean Capital Partners first reported a position in Labcorp in Q2 2017 and held it in 3 quarters.
  • Empyrean Capital Partners's Labcorp position peaked at $95.7M in Q4 2017.
  • 792 funds tracked by Wall St. Rank held Labcorp as of Q1 2018.

Based on Empyrean Capital Partners's 13F filing for Q1 2018, filed 15 May 2018.